Menu
Back to Journals » Drug Design, Development and Therapy » Volume 14
A Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of LiuWei DiHuang Pill in Treating Type 2 Diabetes Mellitus [Corrigendum]
He D, Huang JH, Zhang ZY, et al. Drug Des Devel Ther. 2019;13:3989–4005.
The authors missed to mention equal contribution of the authors Dan He and Jian Hua Huang in the author list. The revised author list should appear as follows:
Dan He,1,* Jian-Hua Huang,1– 3,* Zhe-Yu Zhang,4 Qing Du,1 Wei-Jun Peng,4 Rong Yu,1,2 Si-Fang Zhang,4 Shui-Han Zhang,1 Yu-Hui Qin1
1Hunan Academy of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410013, People’s Republic of China; 2Hunan Key Laboratory of TCM Prescription and Syndromes Translational Medicine, Changsha, Hunan 410208, People’s Republic of China; 32011 Collaboration and Innovation Center for Digital Chinese Medicine in Hunan, Changsha 410013, People’s Republic of China; 4Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, People’s Republic of China
*These authors contributed equally to this work
Read the original article
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.